Overview
Randall Ingham is an Oncologist and a Hematologist in Providence, Rhode Island. Dr. Ingham is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Pleuropulmonary Blastoma, Colorectal Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
593 Eddy St, Apc 138, Providence, RI 02903
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Patrick Ott is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Ott is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Gastroesophageal Junction Cancer, Small Cell Lung Cancer (SCLC), Metastatic Uveal Melanoma, and Tissue Biopsy.
Dana-Farber Cancer Institute, Inc.
Elizabeth Buchbinder is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Buchbinder is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Vulvar Cancer, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Tissue Biopsy.
The General Hospital Corporation
Keith Flaherty is an Oncologist in Boston, Massachusetts. Dr. Flaherty is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, Tissue Biopsy, and Nephrectomy. Dr. Flaherty is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic B-Cell Leukemia (CBCL)Dr. Ingham isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Colorectal CancerDr. Ingham isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Ingham isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Ingham isAdvanced. Learn about Familial Prostate Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Experienced
- Adult Immune ThrombocytopeniaDr. Ingham isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Ingham isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Ingham isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ingham isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Ingham isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Ingham isExperienced. Learn about Antiphospholipid Syndrome.